4-Chloro-5-sulfamoylanthranilic Acid structure
|
Common Name | 4-Chloro-5-sulfamoylanthranilic Acid | ||
---|---|---|---|---|
CAS Number | 3086-91-7 | Molecular Weight | 250.65900 | |
Density | 1.726g/cm3 | Boiling Point | 549.2ºC at 760mmHg | |
Molecular Formula | C7H7ClN2O4S | Melting Point | 267°C (dec.) (lit.) | |
MSDS | N/A | Flash Point | 286ºC | |
Symbol |
GHS07 |
Signal Word | Warning |
Name | 2-amino-4-chloro-5-sulfamoylbenzoic acid |
---|---|
Synonym | More Synonyms |
Density | 1.726g/cm3 |
---|---|
Boiling Point | 549.2ºC at 760mmHg |
Melting Point | 267°C (dec.) (lit.) |
Molecular Formula | C7H7ClN2O4S |
Molecular Weight | 250.65900 |
Flash Point | 286ºC |
Exact Mass | 249.98200 |
PSA | 131.86000 |
LogP | 2.63010 |
Index of Refraction | 1.665 |
Symbol |
GHS07 |
---|---|
Signal Word | Warning |
Hazard Statements | H315-H319-H335 |
Precautionary Statements | P305 + P351 + P338 |
Hazard Codes | N |
RIDADR | NONH for all modes of transport |
HS Code | 2935009090 |
~51% 4-Chloro-5-sulf... CAS#:3086-91-7 |
Literature: NITROMED, INC. Patent: WO2006/55542 A2, 2006 ; Location in patent: Page/Page column 69-70 ; WO 2006/055542 A2 |
~% 4-Chloro-5-sulf... CAS#:3086-91-7 |
Literature: Journal of the American Chemical Society, , vol. 81, p. 5508 Journal of the American Chemical Society, , vol. 82, p. 2731,2733,2734 US2952680 , ; US2910488 , ; |
~% 4-Chloro-5-sulf... CAS#:3086-91-7 |
Literature: Journal of the American Chemical Society, , vol. 81, p. 5508 Journal of the American Chemical Society, , vol. 82, p. 2731,2733,2734 US2952680 , ; US2910488 , ; |
~% 4-Chloro-5-sulf... CAS#:3086-91-7 |
Literature: Journal of the American Chemical Society, , vol. 81, p. 5508 Journal of the American Chemical Society, , vol. 82, p. 2731,2733,2734 |
~29% 4-Chloro-5-sulf... CAS#:3086-91-7 |
Literature: Tetrahedron, , vol. 67, # 49 p. 9518 - 9521 |
HS Code | 2935009090 |
---|---|
Summary | 2935009090 other sulphonamides VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:35.0% |
The use of HPLC to elucidate the metabolism and urinary excretion of furosemide and its metabolic products.
Acta Pharmacol. Toxicol. (Copenh.) 49(3) , 223-9, (1981) Three principles for the use of HPLC with spectrophotometric detection to determine the concentration of furosemide and of 4-chloro-5-sulfamoyl anthranilic acid (CSA) were studied. A reversed phase mi... |
|
The binding of furosemide to serum proteins in elderly patients: displacing effect of phenprocoumon.
Acta Pharmacol. Toxicol. (Copenh.) 47(3) , 202-7, (1980) The percentual binding of furosemide (5 micrograms/ml) was slightly but significantly lower in serum from elderly patients than in serum from normal blood donors (96.5 +/- 0.7 versus 97.9 +/- 0.3). A ... |
|
Furosemide accelerates gentamicin accumulation in cultured renal cells (LLC-PK1 cells).
Nephron 53(2) , 138-41, (1989) Furosemide is known to potentiate gentamicin nephrotoxicity. The mechanism of potentiation is unclear. In our previous studies, we demonstrated that furosemide enhanced gentamicin accumulation in rabb... |
4-Chloro-5-sulfamoylanthranilic acid |
2-AMINO-5-AMINOSULFONYL-4-CHLOROBENZOIC ACID |
4-chloro-5-sulphamoyl anthranilic acid |
Desfurylmethylfurosemide |
Saluamine |
2-amino-4-chloro-5-sulfamoyl-benzoic acid |
Furosemide Related Compound B |
EINECS 221-408-7 |
4-chloro-5-sulfamoyl-anthranilic acid |
4-Chloro-5-sulfanilanthranilic acid |